Antibody

Building multifunctional biologics to treat disease

Read more

Why industry is investing in bispecific molecules

Read more

Humabs BioMedSA: Antibodies for infectious disease

Read more

Commentary: Alphabodies - working inside the cell

Read more

A scenario for shortening drug development times

Read more

MorphoSys Innovation Capital: A venture fund with appetite for platforms

Read more

Fully human antibodies - myths and magic bullets

Read more

2012 was the year of the antibody developer

Read more

Antibodies and ADCs lead cancer pipeline

Read more

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

Read more